Soleno Therapeutics, Inc. · NASDAQ:SLNO
BlackRock, Inc. reported a 6.90% stake in Soleno Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed Apr 24, 2026
BlackRock, Inc. reported a 6.90% stake in Soleno Therapeutics, Inc., 3,543,296 shares, as a passive investor on Mar 31, 2026. Filed Apr 24, 2026 (Schedule 13G/A).
- Stake
- 6.90%
- Shares
- 3,543,296
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 6.90% | 3,543,296 |
Source
Related
- Soleno Therapeutics, Inc.
- BlackRock, Inc.
- Soleno Therapeutics, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Jul 17, 2025
- Schedule 13G/A · BlackRock, Inc. · Feb 5, 2025
- Schedule 13G/A · Wellington Management Group LLP · Aug 13, 2026
- Form 4 · Yen Kristen · May 18, 2026
- Form 4 · Volck Birgitte · May 18, 2026
- Form 4 · Sinclair Andrew · May 18, 2026
- Form 4 · Pauls Matthew · May 18, 2026